文献速递新发突发、热带与寄生虫病

蚊媒传播吡丙醚用于巴西贝洛奥里藏特蚊媒疾病控制:一项实用性前后对照干预配对序列试验

Mosquito-disseminated pyriproxyfen for mosquito-borne disease control in Belo Horizonte, Brazil: a pragmatic, before-after control-intervention paired-series trial.
PubMed 文献 · Lancet Infect Dis · 2024-09-19

该实用性前后对照干预配对序列试验在巴西贝洛奥里藏特九个高登革热流行社区部署2481个吡丙醚扩散站并每月维护,以其余258个社区为对照,基于2016年1月1日至2019年12月31日周-社区登革热病例计数分析,干预社区登革热发病率净平均下降29%(95%CI 21-36),缓冲社区净平均下降21%(12-30)。

要点

  • 干预社区登革热发病率净平均下降29%(95%CI 21-36;p=4.7×10⁻¹⁰)。
  • 缓冲社区登革热发病率净平均下降21%(95%CI 12-30;p=2.7×10⁻⁵)。
  • 寨卡和基孔肯雅病例太少,无法进行可靠评估。

核心结论

  • 结果提示,在真实世界病媒控制干预的诸多操作限制下,尽管覆盖不完整且干预效应可能被稀释,蚊媒传播吡丙醚仍有助于预防登革热。
  • 蚊媒传播吡丙醚有望成为登革热控制的附加工具。

研究设计与样本

  • 实用性、前后对照干预配对序列(BACIPS)试验,在巴西贝洛奥里藏特开展。
  • 市政病媒控制人员于2017年11月至2019年12月每月维护九个相邻社区中的2481个吡丙醚扩散站,九个相邻社区设为缓冲区和其余258个城市社区为对照区。
  • 主要流行病学结局为登革热发病率,基于2016年1月1日至2019年12月31日按周和社区划分的官方登革热通报记录(周-社区病例计数;总计N=265 162例),采用BACIPS方法和负二项广义线性混合模型(GLMM)估计干预效应。

主要发现

  • 周-社区登革热发病率为0至379.5例/1万居民,2016年和2019年记录到流行暴发。
  • 意向性治疗BACIPS-GLMM调整估计显示,部署蚊媒传播吡丙醚与干预社区登革热发病率净平均下降29%(95%CI 21-36;p=4.7×10⁻¹⁰)相关。
  • 缓冲社区登革热发病率净平均下降21%(95%CI 12-30;p=2.7×10⁻⁵)。
  • 干预前各区域间平均发病率在统计学上无法区分(干预区p=0.47;缓冲区p=0.11),对照社区各试验期间平均发病率在统计学上无法区分(p=0.74),部分因不确定性较大。
  • 在10万例暴发这一常见情景下,公共卫生管理者可预期蚊媒传播吡丙醚至少减少约29 000例(21 000-36 000)有症状病例对卫生系统的压力。

关键数值与推荐

  • 干预社区登革热发病率净平均下降29%(95%CI 21-36;p=4.7×10⁻¹⁰)。
  • 缓冲社区登革热发病率净平均下降21%(95%CI 12-30;p=2.7×10⁻⁵)。
  • 10万例暴疫情景下,可预期至少减少约29 000例(21 000-36 000)有症状病例。

临床怎么用

  • 作者认为蚊媒传播吡丙醚有望作为登革热控制的附加工具。
  • 在10万例暴发情景下,公共卫生管理者可预期蚊媒传播吡丙醚至少减少约29 000例(21 000-36 000)有症状病例对卫生系统的压力。
  • 寨卡和基孔肯雅病例太少,无法进行可靠评估。

局限性

  • 寨卡和基孔肯雅病例太少,无法进行可靠评估。
  • 干预覆盖不完整且干预效应可能被稀释。
  • 对照社区各试验期间平均发病率比较因不确定性较大而统计学上无法区分(p=0.74)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mosquitoes transmit important human pathogens, including dengue virus, but are notoriously hard to control. Mosquito-disseminated pyriproxyfen (MDPPF) uses the mosquitoes themselves to transfer particles of pyriproxyfen, a potent larvicide and pupicide, from lure dissemination stations to untreated larval habitats. MDPPF can reduce mosquito densities, but possible epidemiological effects remain to be measured. We aimed to investigate whether MDPPF can help curb mosquito-borne disease transmission. METHODS: In this pragmatic, before-after control-intervention paired-series (BACIPS) trial conducted in Belo Horizonte, Brazil, municipal vector-control staff deployed, then serviced monthly (from November, 2017, to December, 2019), 2481 pyriproxyfen dissemination stations in a nine-neighbourhood cluster with a history of high dengue endemicity; nine adjacent neighbourhoods were designated as a buffer area, and the remaining 258 city neighbourhoods as the control area. The primary epidemiological outcome of the trial was dengue incidence. Based on official dengue-notification records broken down by week and neighbourhood (ie, week-neighbourhood case counts; N=265 162 cases in total) from Jan 1, 2016, to Dec 31, 2019, we estimated intervention effects on incidence using a BACIPS approach and negative-binomial generalised linear mixed models (GLMMs). Zika and chikungunya cases were too rare to be assessed with confidence. FINDINGS: Week-neighbourhood dengue incidence ranged from 0 to 379·5 cases per 10 000 residents, with epidemic outbreaks recorded in 2016 and 2019. Intention-to-treat, BACIPS-GLMM adjusted estimates indicate that MDPPF deployment was associated with a net 29% (95% CI 21-36; p=4·7 × 10-10) average decrease of dengue incidence in intervention neighbourhoods and a net 21% (12-30; p=2·7 × 10-5) average decrease in buffer neighbourhoods. In contrast, and due in part to larger uncertainties, average incidence rates were statistically indistinguishable across areas before the intervention (intervention area p=0·47; buffer area p=0·11) and across trial periods in control neighbourhoods (p=0·74). Hence, in the all-too-common scenario of a 100 000-case outbreak, public health managers could expect MDPPF to reduce the strain on the health-care system by at least about 29 000 (21 000-36 000) symptomatic cases. INTERPRETATION: Our results suggest that MDPPF can help prevent dengue under the many operational constraints of real-world vector-control interventions and despite incomplete coverage and potential dilution of intervention effects. MDPPF holds promise as an additional tool for dengue control. FUNDING: Coordenação-Geral de Vigilância de Arboviroses, Secretaria de Vigilância em Saúde e Ambiente, Ministry of Health, Brazil, Secretaria Municipal de Saúde de Belo Horizonte, Brazil, and Fundação de Amparo à Pesquisa do Estado do Amazonas, Brazil.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Abad-Franch F, Carvajal-Cortés JJ, Rabelo ACL, et al. Mosquito-disseminated pyriproxyfen for mosquito-borne disease control in Belo Horizonte, Brazil: a pragmatic, before-after control-intervention paired-series trial. Lancet Infect Dis. 2024. PMID: 39307142. doi:10.1016/S1473-3099(24)00492-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。